MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma (Q80829907)
Jump to navigation
Jump to search
scientific article published on 06 March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma |
scientific article published on 06 March 2008 |
Statements
MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma (English)
A Curioni-Fontecedro
A J Knights
M Tinguely
N Nuber
C Schneider
C W Thomson
L von Boehmer
W Bossart
S Pahlich
H Gehring
H Moch
C Renner
A Knuth